A narcotic analgesic and antitussive. It is metabolized in the liver by ethylmorphine-N-demethylase and used as an indicator of liver function. It is not marketed in the US but is approved for use in various countries around the world. In the US it is a schedule II drug (single-entity) and schedule III drug (in combination products).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Hydrocodone | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Magnesium sulfate | The therapeutic efficacy of Ethylmorphine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Ethylmorphine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Orphenadrine | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Pramipexole | Ethylmorphine may increase the sedative activities of Pramipexole. |
| Ropinirole | Ethylmorphine may increase the sedative activities of Ropinirole. |
| Rotigotine | Ethylmorphine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Ethylmorphine. |
| Sodium oxybate | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Thalidomide | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Alvimopan | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Alvimopan. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Ethylmorphine is combined with Desmopressin. |
| Morphine | The risk or severity of adverse effects can be increased when Morphine is combined with Ethylmorphine. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethylmorphine. |
| Oxycodone | The risk or severity of adverse effects can be increased when Oxycodone is combined with Ethylmorphine. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Ethylmorphine. |
| Naltrexone | The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Naltrexone. |
| Sufentanil | The risk or severity of adverse effects can be increased when Sufentanil is combined with Ethylmorphine. |
| Levorphanol | The risk or severity of adverse effects can be increased when Levorphanol is combined with Ethylmorphine. |
| Remifentanil | The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethylmorphine. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Ethylmorphine. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Oxymorphone is combined with Ethylmorphine. |
| Dezocine | The risk or severity of adverse effects can be increased when Dezocine is combined with Ethylmorphine. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Ethylmorphine. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Ethylmorphine. |
| Diamorphine | The risk or severity of adverse effects can be increased when Diamorphine is combined with Ethylmorphine. |
| Bezitramide | The risk or severity of adverse effects can be increased when Bezitramide is combined with Ethylmorphine. |
| Etorphine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Etorphine. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Dextromoramide. |
| Desomorphine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Desomorphine. |
| Carfentanil | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Carfentanil. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Dihydrocodeine. |
| Alphacetylmethadol | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Alphacetylmethadol. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Dihydromorphine. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Ketobemidone. |
| DPDPE | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with DPDPE. |
| Lofentanil | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Lofentanil. |
| Opium | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Opium. |
| Normethadone | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Normethadone. |
| Piritramide | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Nicomorphine. |
| Meptazinol | The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Carfentanil, C-11. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Ethylmorphine. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Benzhydrocodone. |
| Alfentanil | The risk or severity of adverse effects can be increased when Alfentanil is combined with Ethylmorphine. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Ethylmorphine. |
| Naloxegol | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Naloxegol. |
| Pegvisomant | The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Ethylmorphine. |
| Succinylcholine | The risk or severity of bradycardia can be increased when Succinylcholine is combined with Ethylmorphine. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Ethylmorphine. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ethylmorphine. |
| Mirabegron | The serum concentration of Ethylmorphine can be increased when it is combined with Mirabegron. |
| Mirtazapine | Ethylmorphine may increase the serotonergic activities of Mirtazapine. |
| Fluvoxamine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Fluvoxamine. |
| Citalopram | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Citalopram. |
| Duloxetine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Duloxetine. |
| Sibutramine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Sibutramine. |
| Zimelidine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Dapoxetine. |
| Milnacipran | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Ethylmorphine. |
| Seproxetine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Levomilnacipran. |
| Indalpine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Indalpine. |
| Ritanserin | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Ritanserin. |
| Alaproclate | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Alaproclate. |
| Sertraline | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Sertraline. |
| Paroxetine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Paroxetine. |
| Ethanol | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine. |
| Phentermine | Phentermine may increase the analgesic activities of Ethylmorphine. |
| Pseudoephedrine | Pseudoephedrine may increase the analgesic activities of Ethylmorphine. |
| Benzphetamine | Benzphetamine may increase the analgesic activities of Ethylmorphine. |
| Diethylpropion | Diethylpropion may increase the analgesic activities of Ethylmorphine. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Lisdexamfetamine. |
| Mephentermine | Mephentermine may increase the analgesic activities of Ethylmorphine. |
| MMDA | MMDA may increase the analgesic activities of Ethylmorphine. |
| Midomafetamine | Midomafetamine may increase the analgesic activities of Ethylmorphine. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Ethylmorphine. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may increase the analgesic activities of Ethylmorphine. |
| Tenamfetamine | Tenamfetamine may increase the analgesic activities of Ethylmorphine. |